Septic arthritis (peds): Difference between revisions

 
(25 intermediate revisions by 5 users not shown)
Line 1: Line 1:
== Background ==
''This page is for <u>pediatric</u> patients; for adult patients see [[septic arthritis]].''
 
==Background==
*Most often in pts <3yo
*Most often in patients < 3yo
*MSSA and MRSA are most common causes in all age groups
*MSSA and MRSA are most common causes in all age groups
*Pts w/ SCD, RA and IBD at increased risk
*Patients with sickle cell disease, rheumatoid arthritis, and inflammatory bowel disease are at increased risk
 
== Diagnosis ==


==Clinical Features==
*Neonates
*Neonates
**Do not appear ill
**Do not appear ill
Line 16: Line 15:
**WBC >12K
**WBC >12K


== Work-Up ==
==Differential Diagnosis==
*[[Trauma]]
*[[Septic arthritis]]
*[[Acute Rheumatic Fever]]
*[[Reactive Arthritis (Poststreptococcal)]]
*Gonococcal arthritis
*[[Lyme disease]]
*[[Sickle cell crisis]]
*[[Henoch-Schonlein Purpura (HSP)]]
*[[Legg Calve Perthes Disease]]
*[[Slipped Capital Femoral Epiphysis (SCFE)]]
*[[Osteomyelitis]]
*[[Juvenile Idiopathic Arthritis]]
*[[Transient (Toxic) Synovitis (Hip)]]
*[[Hemophilia]]
*[[Osgood Schlatter Disease]]


==Evaluation==
===Work-Up===
*Labs
*Labs
**CBC, Blood cx, ESR, CRP, Throat cx
**CBC, ESR, CRP, , blood/throat cultures
*Arthrocentesis
*[[Arthrocentesis]]
**Cell count, GS, glucose, cx
**Cell count, gram stain, glucose, cultures
 
<span class="Apple-style-span" style="font-size: 19px; font-weight: bold; ">DDx</span>
 
#Trauma
#Septic arthritis
#[[Acute Rheumatic Fever]]
#[[Reactive Arthritis (Poststreptococcal)]]
#Gonococcal arthritis
#Lyme disease
#Sickle cell crisis
#[[Henoch-Schonlein Purpura (HSP)]]
#[[Legg Calve Perthes Disease]]
#[[Slipped Capital Femoral Epiphysis (SCFE)]]
#Osteomyelitis
#[[Juvenile Idiopathic Arthritis]]
#[[Transient (Toxic) Synovitis (Hip)]]
#Hemophilia
#[[Osgood Schlatter Disease]]


== Treatment ==
===Kocher Criteria===
*One point each
**Non-weight bearing on affected side
**ESR >40mm/hr
**Fever
**WBC >12,000
*Probability by points<ref> Kocher, MS, et al. Differentiating between septic arthritis and transient synovitis of the hip in children: an evidence-based clinical prediction algorithm. J Bone Joint Surg Am. 1999; 81 (12):1662–70.</ref>
**1 of 4 - 3%
**2 of 4 - 40%
**3 of 4 - 93%
**4 of 4 - 99%


#Joint drainage
==Management==
#IV Abx
#Joint drainage/wash out
#IV [[antibiotics]]


{| cellspacing="1" cellpadding="3" border="0" bgcolor="#666666" width="100%"
{| cellspacing="1" cellpadding="3" border="0" bgcolor="#666666" width="100%"
Line 60: Line 69:
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | [[Clindamycin]], 10 milligrams/kg every 6–8 h
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | [[Clindamycin]], 10 milligrams/kg every 6–8 h
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| valign="top" bgcolor="#ffffff" class="font12" align="left" rowspan="5" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Group B&nbsp;''Streptococcus''&nbsp;
| valign="top" bgcolor="#ffffff" class="font12" align="left" rowspan="5" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | [[Group B Streptococcus]]
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | [[Ampicillin]], 50–100 milligrams/kg every 6 h
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | [[Ampicillin]], 50–100 milligrams/kg every 6 h
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
Line 88: Line 97:
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | [[Gram-Negative]] bacilli
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | [[Gram-Negative]] bacilli
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Cefotaxime or ceftriaxone (dosing as above)
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Cefotaxime or [[ceftriaxone]] (dosing as above)
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | ''Haemophilus influenzae''&nbsp;
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | ''Haemophilus influenzae''&nbsp;
Line 113: Line 122:
|}
|}


== Disposition ==
==Disposition==
Admit
*Admit


==See Also==
==See Also==
[[Septic Arthritis (General)]]
*[[Septic Arthritis (General)]]
 
*[[Arthrocentesis]]
[[Arthrocentesis]]
*[[Septic arthritis of the hip (peds)]]
 
== Source ==


Tintinalli
==References==
<references/>


[[Category:Peds]]
[[Category:Pediatrics]]
[[Category:Ortho]]
[[Category:Orthopedics]]
[[Category:ID]]
[[Category:ID]]

Latest revision as of 19:29, 22 October 2020

This page is for pediatric patients; for adult patients see septic arthritis.

Background

  • Most often in patients < 3yo
  • MSSA and MRSA are most common causes in all age groups
  • Patients with sickle cell disease, rheumatoid arthritis, and inflammatory bowel disease are at increased risk

Clinical Features

  • Neonates
    • Do not appear ill
    • Only 50% have fever
  • Older infants, toddlers, children
    • Fever (>101.3), localizing signs
  • Labs
    • CRP >20
    • WBC >12K

Differential Diagnosis

Evaluation

Work-Up

  • Labs
    • CBC, ESR, CRP, , blood/throat cultures
  • Arthrocentesis
    • Cell count, gram stain, glucose, cultures

Kocher Criteria

  • One point each
    • Non-weight bearing on affected side
    • ESR >40mm/hr
    • Fever
    • WBC >12,000
  • Probability by points[1]
    • 1 of 4 - 3%
    • 2 of 4 - 40%
    • 3 of 4 - 93%
    • 4 of 4 - 99%

Management

  1. Joint drainage/wash out
  2. IV antibiotics
Age Suspected Organism Antibiotics
Newborn (0–2 mo) Staphylococcus aureus Vancomycin, 10 milligrams/kg every 6–8 h
or 
Clindamycin, 10 milligrams/kg every 6–8 h
Group B Streptococcus Ampicillin, 50–100 milligrams/kg every 6 h
and 
Cefotaxime, 50 milligrams/kg every 6–8 h
or 
Ceftriaxone, 50 milligrams/kg every 12 h
Gram-negative bacilli Cefotaxime, 50 milligrams/kg every 8 h
Neisseria gonorrhoeae  Cefotaxime, 50 milligrams/kg every 8 h
Unknown Vancomycin or clindamycin and cefotaxime or ceftriaxone (dosing as above)
Infant (2–36 mo) S. aureus Vancomycin or clindamycin (dosing as above)
Streptococcus species Clindamycin/cefotaxime/ceftriaxone (dosing as above)
Gram-Negative bacilli Cefotaxime or ceftriaxone (dosing as above)
Haemophilus influenzae  Cefotaxime or ceftriaxone (dosing as above)
Unknown Vancomycin or clindamycin and cefotaxime or ceftriaxone
Child (>36 mo) S. aureus Vancomycin or clindamycin
Streptococcus species  Clindamycin/cefotaxime/ceftriaxone
Gram-negative bacilli Cefotaxime or ceftriaxone
N. gonorrhoeae Cefotaxime or ceftriaxone
Unknown Vancomycin or clindamycin and cefotaxime or ceftriaxone

Disposition

  • Admit

See Also

References

  1. Kocher, MS, et al. Differentiating between septic arthritis and transient synovitis of the hip in children: an evidence-based clinical prediction algorithm. J Bone Joint Surg Am. 1999; 81 (12):1662–70.